D
Alimera Sciences, Inc. ALIM
$5.54 -$0.01-0.18%
Recommendation
Sell
Prev Close
$5.54
Volume
2,679,904
Avg Vol (90D)
668,082
Market Cap
$301.29M
Dividend & Yield
--
52-Week Range
$2.61 - $5.65
P/E (TTM)
--
EPS (TTM)
-$0.3055
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Good
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Stonepine Capital Management LLC Sells 539,256 Shares of Alimera Sciences, Inc. (NASDAQ:ALIM)
10/1/2024 - Zolmax
Alimera Sciences (NASDAQ:ALIM) Now Covered by Analysts at StockNews.com
10/1/2024 - Ticker Report
Alimera Sciences (NASDAQ:ALIM) Coverage Initiated at StockNews.com
10/1/2024 - Zolmax
Alimera Sciences (NASDAQ:ALIM) Coverage Initiated by Analysts at StockNews.com
9/23/2024 - Ticker Report
ANI Pharmaceuticals' Acquisition of Alimera Sciences Bolsters Buy Rating and $94 Target Price
9/17/2024 - TipRanks Financial Blog
ANI Pharmaceuticals completes purchase of Alimera Sciences
9/16/2024 - SeekingAlpha.com: All News
ANI Pharmaceuticals completes purchase of Alimera Sciences
9/16/2024 - Seeking Alpha - Healthcare
ANI Pharmaceuticals completes acquisition of Alimera Sciences
9/16/2024 - The Fly
ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
9/16/2024 - Globe Newswire
ANI Pharmaceuticals initiates closing of acquisition of Alimera Sciences
9/16/2024 - The Fly
ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences
9/16/2024 - Globe Newswire
The volume for Alimera Sciences stock increased for one day, resulting in a record-breaking daily growth of 208% of the 65-Day Volume Moving Average
9/14/2024 - Tickeron - Technical Analysis
Alimera Sciences (NASDAQ:ALIM) Coverage Initiated by Analysts at StockNews.com
9/14/2024 - Zolmax
Alimera Sciences (NASDAQ:ALIM) Now Covered by Analysts at StockNews.com
9/14/2024 - Ticker Report
Alimera Sciences (ALIM) Soars 6.6%: Is Further Upside Left in the Stock?
9/12/2024 - Zacks Investment Research
Alimera Sciences (ALIM, $5.53) RSI Indicator left the oversold zone on September 11, 2024
9/12/2024 - Tickeron - Stocks
Alimera Sciences: Deal Closing After All, CVR Still Attractive
9/11/2024 - SeekingAlpha
ANI Pharmaceuticals, Alimera Sciences deal set to close Monday
9/11/2024 - Seeking Alpha - Healthcare
ANI Pharmaceuticals, Alimera Sciences merger to close on September 16
9/11/2024 - The Fly
ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
9/11/2024 - Business Wire
ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
9/11/2024 - Globe Newswire
Alimera Sciences (ALIM, $5.19) price may climb as it broke lower Bollinger Band on Sep 10, 2024
9/11/2024 - Tickeron - Technical Analysis
Alimera Sciences (ALIM, $5.19) RSI Indicator left the oversold zone on September 10, 2024
9/11/2024 - Tickeron - Technical Analysis
Alimera Sciences falls after it sues ANI Pharmaceuticals to close deal (update)
9/10/2024 - SeekingAlpha.com: All News
Alimera Sciences trading resumes
9/10/2024 - The Fly
Income Statement
Total Revenue (TTM)
$99.68M
EBITDA (TTM)
$14.78M
EBIT (TTM)
$2.40M
Net Income (TTM)
-$14.70M
Balance Sheet
Total Assets (Q)
$150.38M
Total Debt (Q)
$72.45M
Total Liabilities (Q)
$111.59M
Book Value Per Share (Q)
$0.7404
Cash Flow
Cash from Operations (TTM)
-$5.60M
Cash from Investing (TTM)
-$221.00K
Cash from Financing (TTM)
-$1.97M
Net Change in Cash (TTM)
-$7.95M
Filings
Filing Date
Wednesday, August 7, 2024
Period Date
Sunday, June 30, 2024
Next Filing
Beginning of November (est)
Price History
Loading...
Beta
0.47
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Oct 16, 2023 - $2.61
52-week High
Jun 24, 2024 - $5.65
Valuation
Market Cap
$301.29M - Small Cap
Enterprise Value
$362.91M
Price/Sales (TTM)
3.02
Price/Book (Q)
7.48
Dividends and Shares
Shares Outstanding
54.38M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
alimerasciences.com
Phone Number
678 990 5740
Address
6310 Town Square
Alpharetta, GA 30005
Country
United States
Year Founded
2003
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Alimera Sciences, Inc., a pharmaceutical company, develops and commercializes prescription ophthalmic retinal pharmaceuticals. It operates through United States, International, and Operating Cost... more
NASDAQ 09/13/2024 4:00PM Eastern Quotes delayed
Weiss Ratings